ERBB2 and cancer: In hormone receptor–positive (Luminal) cancers, ALKBH7 may support cell proliferation by maintaining mitochondrial homeostasis and metabolic flexibility, whereas in more aggressive HER2+ and TNBC subtypes, it may promote cellular adaptation to stress through enhanced oxidative phosphorylation and the suppression of apoptosis.